<DOC>
	<DOC>NCT00767507</DOC>
	<brief_summary>The purpose of this study is to demonstrate that patients receiving cangrelor infusion before coronary artery bypass grafting have an acceptable safety profile and can undergo surgery without excessive bleeding peri-operatively.</brief_summary>
	<brief_title>Maintenance of Platelet Inhibition With Cangrelor</brief_title>
	<detailed_description />
	<mesh_term>Acute Coronary Syndrome</mesh_term>
	<mesh_term>Cangrelor</mesh_term>
	<criteria>Written informed consent 18 Years of Age Non emergent coronary bypass graft surgery Received a thienopyridine within 48 hours prior to enrollment Confirmed or suspected pregnancy Cerebrovascular accident within one yar Intracranial neoplasm History of bleeding diathesis Thrombocytopenia</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>February 2014</verification_date>
</DOC>